Axitinib AG-013736
Laufzeit: 01.01.2008 - 31.12.2009
imported
Kurzfassung
Axitinib as second line therapy for metastatic renal cell cancer: Axis Trial
Laufzeit: 01.01.2008 - 31.12.2009
Axitinib as second line therapy for metastatic renal cell cancer: Axis Trial